Not Tagged
pfizer
[]
see updated antitumor activity, safety &amp; biomarker data from an ongoing ph 3 safety lead-in study evaluating a brafi &amp; egfri combination w/ or w/o chemo vs soc chemo alone in pts w/ brafv600e mutant metastatic
#colorectalcancer at asco #gi23 119 
Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/MU3blmItSZ